Vitrolife Balance Sheet Health
Financial Health criteria checks 4/6
Vitrolife has a total shareholder equity of SEK13.1B and total debt of SEK2.0B, which brings its debt-to-equity ratio to 15.2%. Its total assets and total liabilities are SEK16.9B and SEK3.8B respectively. Vitrolife's EBIT is SEK777.0M making its interest coverage ratio 10. It has cash and short-term investments of SEK853.0M.
Key information
15.2%
Debt to equity ratio
SEK 1.99b
Debt
| Interest coverage ratio | 10x |
| Cash | SEK 853.00m |
| Equity | SEK 13.10b |
| Total liabilities | SEK 3.76b |
| Total assets | SEK 16.85b |
Recent financial health updates
Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt
Apr 03
Is Vitrolife (STO:VITR) A Risky Investment?
Nov 06Vitrolife (STO:VITR) Could Easily Take On More Debt
Aug 03Is Vitrolife (STO:VITR) A Risky Investment?
Jan 23Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly
Oct 18Is Vitrolife (STO:VITR) A Risky Investment?
Jul 07Recent updates
Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)
Aug 21Vitrolife AB (publ) Just Beat EPS By 16%: Here's What Analysts Think Will Happen Next
Jul 20Vitrolife AB (publ) (STO:VITR) Shares Fly 32% But Investors Aren't Buying For Growth
Jul 18Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt
Apr 03A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Mar 07Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now
Feb 05Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion
Jan 05Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching
Dec 15Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)
Nov 27Is Vitrolife (STO:VITR) A Risky Investment?
Nov 06An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued
Aug 25Vitrolife (STO:VITR) Could Easily Take On More Debt
Aug 03Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?
May 26Is Vitrolife (STO:VITR) A Risky Investment?
Jan 23Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly
Oct 18Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Sep 09Is Vitrolife (STO:VITR) A Risky Investment?
Jul 07A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)
May 26Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly
Mar 31Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)
Feb 07There May Be Reason For Hope In Vitrolife's (STO:VITR) Disappointing Earnings
Apr 29Financial Position Analysis
Short Term Liabilities: VITR's short term assets (SEK2.0B) exceed its short term liabilities (SEK669.0M).
Long Term Liabilities: VITR's short term assets (SEK2.0B) do not cover its long term liabilities (SEK3.1B).
Debt to Equity History and Analysis
Debt Level: VITR's net debt to equity ratio (8.7%) is considered satisfactory.
Reducing Debt: VITR's debt to equity ratio has increased from 0% to 15.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable VITR has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: VITR is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 19.6% per year.